Profil
Yoni Livne is currently the Chief Financial Officer at Bonus Biogroup Ltd. He previously worked as the Chief Financial Officer at Real Imaging Holdings Ltd. and as the Chief Controller at Dexcel Pharma Technologies Ltd. Livne received an undergraduate degree and an MBA from The Hebrew University of Jerusalem.
Postes actifs de Yoni Livne
| Sociétés | Poste | Début |
|---|---|---|
| BONUS BIOGROUP LTD. | Directeur Financier/CFO | 01/06/2014 |
Anciens postes connus de Yoni Livne
| Sociétés | Poste | Fin |
|---|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes generic pharmaceuticals products | Comptroller/Controller/Auditor | - |
Real Imaging Holdings Ltd.
Real Imaging Holdings Ltd. Medical SpecialtiesHealth Technology Develops imaging solution for breast cancer detection | Directeur Financier/CFO | - |
Formation de Yoni Livne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bonus Biogroup Ltd.
Bonus Biogroup Ltd. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops regeneration therapies and biotechnology products for bones | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Real Imaging Holdings Ltd.
Real Imaging Holdings Ltd. Medical SpecialtiesHealth Technology Develops imaging solution for breast cancer detection | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes generic pharmaceuticals products | Health Technology |
















